EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demonstrated significant benefits by reducing treatment frequency by 38%, with many patients requiring fewer supplemental injections and maintaining strong anatomical control. The drug also showed a favorable safety profile with redosing. EyePoint plans further analysis of combined trial data and continues to advance DURAVYU's development for diabetic macular edema (DME), with pivotal trial results expected in late 2027.
EyePoint's DURAVYU trial results provide context for health sector stocks. For readers following health stocks, here is Pluang's market snapshot as of Oct 19, 2026 17:11 WIB: Of 150 priced US health stocks, 69 rose and 45 fell. Notable movers include CTXR at USD 0.48 (+4.13%), SANA at USD 2.33 (+2.64%), and CYTK at USD 63.50 (+2.50%). Typical hold times range from 17 to 24 days.
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...
Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...
JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...
Haleon Canada is opening the Haleon Health House in Toronto on October 23, an immersive pop-up experience designed to educate visitors on everyday health through interactive exhibits and expert advice. The event features trusted Haleon brands like Ad...
